富氧空气对毛细血管前肺动脉高压患者运动表现的影响:随机假对照交叉试验
该随机、假对照、单盲交叉试验纳入22例肺动脉高压或慢性血栓栓塞性肺动脉高压患者,比较富氧空气(FiO2 0.50)与室内空气(FiO2 0.21)对运动表现的影响。结果显示富氧空气使递增运动最大功率从113±38 W增至132±48 W,恒负荷运动耐力从571±443 s增至1242±514 s。作者认为患者可能从日常活动和训练中的氧疗获益。
要点
- 富氧空气使递增运动最大功率平均增加19.7 W(95%CI 10.5-28.9,P<0.001)。
- 富氧空气使恒负荷运动耐力平均增加671 s(95%CI 392-951,P<0.001)。
- 作者认为PAH/CTEPH患者可能从日常活动和训练中的氧疗获益。
核心结论
- 在PAH/CTEPH患者中,呼吸富氧空气可大幅提高运动表现,与动脉氧合改善促进肌肉和脑氧利用及降低过度通气反应有关。
- 作者认为PAH/CTEPH患者可能因此从日常体力活动和训练中的氧疗获益。
研究设计与样本
- 随机、假对照、单盲、交叉试验,纳入22例肺动脉高压或慢性血栓栓塞性肺动脉高压患者(女性8例,年龄61±14岁,静息mPAP 35±9 mmHg,室内空气PaO2>7.3 kPa)。
- 患者在不同日期进行四次自行车负荷运动试验至力竭,分别呼吸富氧空气(FiO2 0.50,高氧)或室内空气(FiO2 0.21,常氧),采用递增或恒负荷方案(恒负荷为FiO2 0.21下最大功率的75%)。
- 监测心电图、肺气体交换、动脉血气及近红外光谱测定的脑和股四头肌组织氧合。
- 试验注册号:clinicaltrials.gov NCT01748474。
主要发现
- 递增运动:最大功率常氧组113±38 W vs 高氧组132±48 W,平均差异19.7 W(95%CI 10.5-28.9),P<0.001。
- 恒负荷运动:耐力常氧组571±443 s vs 高氧组1242±514 s,平均差异671 s(95%CI 392-951),P<0.001。
- 高氧运动结束时PaO2、脑组织氧合、股四头肌组织氧合及PaCO2升高,CO2通气当量降低,生理死腔/潮气量比值不变。
临床怎么用
- 原文结论指出PAH/CTEPH患者可能从日常体力活动和训练中的氧疗获益,作者认为可能受益。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The purpose of the current trial was to test the hypothesis that breathing oxygen-enriched air increases exercise performance of patients with pulmonary arterial or chronic thrombo-embolic pulmonary hypertension (PAH/CTEPH) and to investigate involved mechanisms. METHODS AND RESULTS: Twenty-two patients with PAH/CTEPH, eight women, means ± SD 61 ± 14 years, resting mPAP 35 ± 9mmHg, PaO2 ambient air >7.3 kPa, underwent four bicycle ergospirometries to exhaustion on different days, while breathing oxygen-enriched (FiO2 0.50, hyperoxia) or ambient air (FiO2 0.21, normoxia) using progressively increased or constant load protocols (with 75% maximal work rate under FiO2 0.21), according to a randomized, sham-controlled, single-blind, cross-over design. ECG, pulmonary gas-exchange, arterial blood gases, cerebral and quadriceps muscle tissue oxygenation (CTO and QMTO) by near-infrared spectroscopy were measured. In ramp exercise, maximal work rate increased from 113 ± 38 W with normoxia to 132 ± 48 W with hyperoxia, mean difference 19.7 (95% CI 10.5-28.9) W, P < 0.001. Constant load exercise endurance increased from 571 ± 443 to 1242 ± 514 s, mean difference 671 (95% CI 392-951) s, P < 0.001. At end-exercise with hyperoxia PaO2, CTO, QMTO, and PaCO2 were increased, and ventilatory equivalents for CO2 were reduced while the physiological dead space/tidal volume ratio remained unchanged. CONCLUSION: In patients with PAH/CTEPH, breathing oxygen-enriched air provides major increases in exercise performance. This is related to an improved arterial oxygenation that promotes oxygen availability in muscles and brain and to a reduction of the excessive ventilatory response to exercise thereby enhancing ventilatory efficiency. Patients with PAH/CTEPH may therefore benefit from oxygen therapy during daily physical activities and training. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01748474.
引用
- Ulrich S, Hasler ED, Saxer S, et al. Effect of breathing oxygen-enriched air on exercise performance in patients with precapillary pulmonary hypertension: randomized, sham-controlled cross-over trial. Eur Heart J. 2017. PMID: 28329240. doi:10.1093/eurheartj/ehx099
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。